Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | Unknown | — |
Patient received first dose of RabAvert and then got sidetracked and did not come on time for second dose for 13 days; Case reference number US-BN-2024-001914 is a spontaneous case report initially received from a pharmacist via Med Communications (reference number: USBAV24-1030) on 14-May-2024 and concerns a male patient of unspecified age. The patient's relevant medical history and concomitant medications were not provided. On unspecified date, the patient was vaccinated with the first dose of RabAvert (batch number: unknown), at unknown dose, route, or site of administration for pre-exposure. It was reported that the patient was sidetracked, and the patient did not come on time for second dose of RabAvert. As reported, the patient was 13 days out of the first dose of RabAvert (explicitly coded as 'inappropriate schedule of vaccine administered') At the time of initial report, it was unknown if the patient experienced any adverse event due to RabAvert vaccine. No further information provided.; Reporter's Comments: A male patient of unspecified age did not come on time for the second dose of RabAvert, after the patient was vaccinated with the first dose of RabAvert for pre-exposure. As reported, the patient was 13 days out of the first dose of RabAvert, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to RabAvert vaccine. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A male patient of unspecified age did not come on time for the second dose of RabAvert, after the patient was vaccinated with the first dose of RabAvert for pre-exposure. As reported, the patient was 13 days out of the first dose of RabAvert, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to RabAvert vaccine. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None